Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Higher 25(OH)D was observed in participants with negative Δ TRAP5b values (Table 4).

Source: Laboratory correlates of bone marker changes. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Secondary analysis.

Secondary analysis

Analyses existing study data; this paper is not automatically another independent trial.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Markers of bone turnover after 12 months of exercise in patients with chronic kidney disease 3 to 5: a post-hoc analysis of RENEXC: a randomized controlled trial

Source: Article title.

A total of 151 CKD stage 3 to 5 patients were randomly assigned to either strength or balance exercise, both combined with endurance exercise.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Markers of bone turnover after 12 months of exercise in patients with chronic kidney disease 3 to 5: a post-hoc analysis of RENEXC: a randomized controlled trial

Secondary analysis · BMC Nephrology · 2025

Original publication title

Markers of bone turnover after 12 months of exercise in patients with chronic kidney disease 3 to 5: a post-hoc analysis of RENEXC: a randomized controlled trial

Vaida Petrauskiene; Matthias Hellberg; Philippa Svensson; Naomi Clyne

© The Author(s) 2025

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Neither strength nor balance exercise significantly altered bone turnover markers over 12 months in patients with CKD. Nonetheless, both interventions were associated with more participants exhibiting TRAP5b values consistent with low bone turnover, indicating a potential role in mitigating bone resorption. These findings warrant further investigation into the long-term effects of exercise on bone health in CKD, with a particular focus on the mechanisms underlying these responses.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Bone and mineral disorders are common in patients with chronic kidney disease (CKD), leading to poor quality of life, high fracture risk, and increased morbidity and cardiovascular mortality. Parathyroid hormone (PTH) and bone-specific alkaline phosphatase (bALP) are frequently used to assess bone turnover, but markers such as procollagen type I N-terminal propeptide (intact PINP) and tartrate-resistant acid phosphatase isoform 5b (TRAP5b), which reflect bone formation and resorption, may provide more specific insights into bone remodeling. This study aims to investigate the effects of balance and strength exercises on bone turnover markers in patients with CKD not undergoing kidney replacement therapy.

Source: Background

Abstract: What methods does the paper describe?

This study is a post-hoc sub-analysis of the RENEXC trial, a randomized controlled exercise intervention lasting 12 months. A total of 151 CKD stage 3 to 5 patients were randomly assigned to either strength or balance exercise, both combined with endurance exercise. Exercise intensity was monitored using the Borg Rating of Perceived Exertion scale. Bone turnover markers, including intact PINP and TRAP5b, were measured at baseline and after 12 months.

Source: Methods

Abstract: Results

Over 12 months, within-group changes in bone turnover markers were not statistically significant. In the strength group, intact PINP showed a non-significant increase and TRAP5b a slight decrease, while in the balance group intact PINP tended to decrease and TRAP5b remained stable. After adjustment for baseline values, between-group differences at 12 months were small and non-significant for both markers. Overall adjusted means were 78.7 µg/L for intact PINP and 1.87 U/L for TRAP5b, with no significant effects of treatment group, sex, or CKD stage.

Additionally, both exercise groups showed an increase in the proportion of patients with TRAP5b values indicative of low bone turnover, suggesting a possible protective effect on bone resorption.

Source: Results

Abstract: Conclusions

Neither strength nor balance exercise significantly altered bone turnover markers over 12 months in patients with CKD. Nonetheless, both interventions were associated with more participants exhibiting TRAP5b values consistent with low bone turnover, indicating a potential role in mitigating bone resorption. These findings warrant further investigation into the long-term effects of exercise on bone health in CKD, with a particular focus on the mechanisms underlying these responses.

Source: Conclusions
Authors’ abstract

Background

Bone and mineral disorders are common in patients with chronic kidney disease (CKD), leading to poor quality of life, high fracture risk, and increased morbidity and cardiovascular mortality. Parathyroid hormone (PTH) and bone-specific alkaline phosphatase (bALP) are frequently used to assess bone turnover, but markers such as procollagen type I N-terminal propeptide (intact PINP) and tartrate-resistant acid phosphatase isoform 5b (TRAP5b), which reflect bone formation and resorption, may provide more specific insights into bone remodeling. This study aims to investigate the effects of balance and strength exercises on bone turnover markers in patients with CKD not undergoing kidney replacement therapy.

Methods

This study is a post-hoc sub-analysis of the RENEXC trial, a randomized controlled exercise intervention lasting 12 months. A total of 151 CKD stage 3 to 5 patients were randomly assigned to either strength or balance exercise, both combined with endurance exercise. Exercise intensity was monitored using the Borg Rating of Perceived Exertion scale. Bone turnover markers, including intact PINP and TRAP5b, were measured at baseline and after 12 months.

Results

Over 12 months, within-group changes in bone turnover markers were not statistically significant. In the strength group, intact PINP showed a non-significant increase and TRAP5b a slight decrease, while in the balance group intact PINP tended to decrease and TRAP5b remained stable. After adjustment for baseline values, between-group differences at 12 months were small and non-significant for both markers. Overall adjusted means were 78.7 µg/L for intact PINP and 1.87 U/L for TRAP5b, with no significant effects of treatment group, sex, or CKD stage.

Additionally, both exercise groups showed an increase in the proportion of patients with TRAP5b values indicative of low bone turnover, suggesting a possible protective effect on bone resorption.

Conclusions

Neither strength nor balance exercise significantly altered bone turnover markers over 12 months in patients with CKD. Nonetheless, both interventions were associated with more participants exhibiting TRAP5b values consistent with low bone turnover, indicating a potential role in mitigating bone resorption. These findings warrant further investigation into the long-term effects of exercise on bone health in CKD, with a particular focus on the mechanisms underlying these responses.

Trial registration

NCT02041156 at http://www.ClinicalTrials.gov. Date of registration January 20, 2014. Retrospectively registered.

Publication and source details

Original title: Markers of bone turnover after 12 months of exercise in patients with chronic kidney disease 3 to 5: a post-hoc analysis of RENEXC: a randomized controlled trial

Vaida Petrauskiene; Matthias Hellberg; Philippa Svensson; Naomi Clyne

BMC Nephrology · 2025

© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Lund University

Open access funding provided by Lund University.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T02:29:13.463146+00:00

DOI: 10.1186/s12882-025-04501-9 · PMC12519816